DNAtrixInc.
Interferon-gamma(DNAtrix, Inc.)은 Glioblastoma or Gliosarcoma 표적 세포·유전자 치료로, Glioblastoma or Gliosarcoma 영역에서 개발·상용화 중입니다. 작용기전: of Synotis solidaginea in treating acute eczema based on ultra performance liquid chromatography-linear trap quadrupole-Orbitrap mass spectrometry， network pharmacology and . Phase 1 안전성·PK 탐색 단계입니다. OS: 97. 차별점: novel use of silibinin as a preventive agent in a PE-like model that reproduces essential features of human PE, providing phy.
Glioblastoma or Gliosarcoma
Glioblastoma or Gliosarcoma
Active
NK cells
humanized antibody capable of recognizing both LILRB3 and LILRB4
novel use of silibinin as a preventive agent in a PE-like model that reproduces essential features of human PE, providing phy
of Synotis solidaginea in treating acute eczema based on ultra performance liquid chromatography-linear trap quadrupole-Orbitrap mass spectrometry， network pharmacology and animal experiments]
T cell proliferation and activation
apoptosis and epithelial-mesenchymal transition reversal
PD-L1 therapy, reduced CD8 + T-cell infiltration, and attenuated MHC-I expression
downregulation or loss of S1PR3 expression might be used for the diagnosis of PDAC and is closely associated with the malignant progre
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
DNAtrixInc.
Interferon-gamma(DNAtrix, Inc.)은 Glioblastoma or Gliosarcoma 표적 세포·유전자 치료로, Glioblastoma or Gliosarcoma 영역에서 개발·상용화 중입니다. 작용기전: of Synotis solidaginea in treating acute eczema based on ultra performance liquid chromatography-linear trap quadrupole-Orbitrap mass spectrometry， network pharmacology and . Phase 1 안전성·PK 탐색 단계입니다. OS: 97. 차별점: novel use of silibinin as a preventive agent in a PE-like model that reproduces essential features of human PE, providing phy.
Glioblastoma or Gliosarcoma
Glioblastoma or Gliosarcoma
Active
NK cells
humanized antibody capable of recognizing both LILRB3 and LILRB4
novel use of silibinin as a preventive agent in a PE-like model that reproduces essential features of human PE, providing phy
of Synotis solidaginea in treating acute eczema based on ultra performance liquid chromatography-linear trap quadrupole-Orbitrap mass spectrometry， network pharmacology and animal experiments]
T cell proliferation and activation
apoptosis and epithelial-mesenchymal transition reversal
PD-L1 therapy, reduced CD8 + T-cell infiltration, and attenuated MHC-I expression
downregulation or loss of S1PR3 expression might be used for the diagnosis of PDAC and is closely associated with the malignant progre
차트 로드 중…
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.